Coronavirus dashboard: emphasis on testing
Beleaguered Hertz Sinks 36% In After-Market On Bankruptcy Protection Filing
Now Back To Our Regularly Scheduled Program, Doubting ‘Global Growth’
Mapping Facial Recognition Technology Around the World
Bad news and good news on coronavirus; plus, implications for Election Day
Investing in Casino and iGaming Stocks
2 Top Cruise Line Stocks to Buy and 1 to Avoid During the Coronavirus Crisis
Foreign direct investment and global value chains in the wake of COVID-19: Lead firms of GVC
Mid-Market Update: Unimpressive US data, China’s Countermeasures, Oil higher and Gold lower on Manufacturing recovery
Need some good news? Markets, economy do offer some
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
Coronavirus – weekly update – 20 May 2020
A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market
Fed Funds Futures No Longer Imply Negative Rates
China Leaves Rates Unchanged. Japan Machinery Orders Rebound
Ring, Ring, Hündchen
Dynavax Explodes 40% In Pre-Market On Phase 1 Covid-19 Vaccine News
Daily market commentary: COVID-19 vaccination rumours diminishing investors’ appetite for safe haven assets
Moderna Prices $1.3B Equity Offering at $76/Share
From Cash to Crypto: COVID-19 Is Changing the Way the World Sees Money
High five! It’s possible to create proximity online
Moderna Spikes 21% Amid “Positive” Early-Stage Covid-19 Vaccine Data
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
Which jobs are most at risk because of COVID-19?
Ryanair Cuts Traffic Target By Almost 50% For Coming Year, Seeks To Reduce Boeing Plane Deliveries
Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days
Yuan Slumps as US-Chinese Tensions Rise
What is our “variant perception” to the market?
Reopening Trump’s Trade: Gold Is On The Move